The transition of medication overuse status by acute medication categories in episodic or chronic migraine patients to non-overuse status after receiving anti-CGRP monoclonal antibodies: a systematic review and meta-analysis of phase 3 randomized control trial

Simple item page
dc.contributor.authorChananchida Sirilertmekasakul
dc.contributor.authorAkkanat Panto
dc.contributor.authorPattanan Lekhalawan
dc.contributor.authorP Panyarachun
dc.contributor.authorP Jindasakchai
dc.contributor.authorWanakorn Rattanawong
dc.date.accessioned2026-05-08T19:16:30Z
dc.date.issued2024-4-2
dc.identifier.doi10.1007/s10072-024-07496-7
dc.identifier.urihttps://dspace.kmitl.ac.th/handle/123456789/15556
dc.publisherNeurological Sciences
dc.subjectMigraine and Headache Studies
dc.subjectNeurological Complications and Syndromes
dc.subjectCardiovascular Syncope and Autonomic Disorders
dc.titleThe transition of medication overuse status by acute medication categories in episodic or chronic migraine patients to non-overuse status after receiving anti-CGRP monoclonal antibodies: a systematic review and meta-analysis of phase 3 randomized control trial
dc.typeReview

Files

Collections

All